NEW YORK (dpa-AFX Broker) - The research firm Jefferies has reduced its price target for Siemens from 291 to 277 euros, while maintaining its "Buy" rating. In his assessment on Friday, Rizk Maidi wrote that Siemens is likely to reduce its stake in its medical technology subsidiary, Siemens Healthineers, to below 60 percent before a direct spin-off. This move would pave the way for a focused industrial group with a unique AI industrial platform. Maidi expects Siemens' medium-term revenue growth to outpace its competitors. After 2026, he forecasts double-digit percentage growth in earnings per share (EPS). By 2030, software is projected to account for around 50 percent of revenue in the Digital Industries (DI) division. However, the analyst has lowered his profit forecasts and price target to reflect currency effects, integration costs from acquisitions, and higher expenditures. Siemens remains a core holding in the industrial sector.

Original study publication: 21.11.2025 / 11:22 / Time zone not specified in the study
First dissemination of the original study: 23.11.2025 / 19:00 / Time zone not specified in the study

-----------------------

dpa-AFX Broker - the trader news from dpa-AFX

-----------------------